Related Experiment Video
Updated: Mar 25, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
Published on: May 16, 2012
Deletion of Interstitial Genes between TMPRSS2 and ERG Promotes Prostate Cancer Progression
Douglas E Linn1, Kathryn L Penney2, Roderick T Bronson3
1Division of Genetics, Brigham and Women's Hospital and Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Abstract:
TMPRSS2-ERG gene fusions that occur frequently in human prostate cancers can be generated either through insertional chromosomal rearrangement or by intrachromosomal deletion. Genetically, a key difference between these two mechanisms is that the latter results in deletion of a ∼3-Mb interstitial region containing genes with unexplored roles in prostate cancer. In this study, we characterized two mouse models recapitulating TMPRSS2-ERG insertion or deletion events in the background of prostate-specific PTEN deficiency. We found that only the mice that lacked the interstitial region developed prostate adenocarcinomas marked by poor differentiation and epithelial-to-mesenchymal transition. Mechanistic investigations identified several interstitial genes, including Ets2 and Bace2, whose reduced expression correlated in the gene homologs in human prostate cancer with biochemical relapse and lethal disease. Accordingly, PTEN-deficient mice with prostate-specific knockout of Ets2 exhibited marked progression of prostate adenocarcinomas that was partly attributed to activation of MAPK signaling. Collectively, our findings established that Ets2 is a tumor suppressor gene in prostate cancer, and its loss along with other genes within the TMPRSS2-ERG interstitial region contributes to disease progression. Cancer Res; 76(7); 1869-81. ©2016 AACR.
Insights
Loss of genes in the TMPRSS2-ERG interstitial region, including Ets2, drives aggressive prostate cancer. This deletion promotes tumor progression and poor differentiation in PTEN-deficient mice, highlighting Ets2 as a tumor suppressor.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- TMPRSS2-ERG gene fusions are common in prostate cancer, arising from chromosomal rearrangements or deletions.
- Intrachromosomal deletion removes a ~3-Mb interstitial region with largely unexplored genes relevant to prostate cancer.
Purpose of the Study:
- To investigate the role of the interstitial region deleted during TMPRSS2-ERG fusion formation in prostate cancer development.
- To characterize mouse models mimicking TMPRSS2-ERG insertion or deletion in PTEN-deficient prostates.
Main Methods:
- Development and analysis of two distinct mouse models for TMPRSS2-ERG rearrangement.
- Prostate-specific PTEN deficiency was introduced into the mouse models.
- Gene expression analysis and mechanistic investigations of interstitial genes, including Ets2 and Bace2.
Main Results:
- Mice lacking the interstitial region developed aggressive prostate adenocarcinomas with poor differentiation and epithelial-to-mesenchymal transition.
- Reduced expression of interstitial genes Ets2 and Bace2 correlated with biochemical relapse and lethal disease in human prostate cancer.
- Knockout of Ets2 in PTEN-deficient mice accelerated prostate adenocarcinoma progression, partly via MAPK signaling activation.
Conclusions:
- The deleted interstitial region contains tumor suppressor genes critical for prostate cancer progression.
- Ets2 functions as a tumor suppressor in prostate cancer, and its loss contributes to disease aggressiveness.
- Loss of Ets2 and other interstitial genes promotes prostate cancer development and progression.
Related Concept Videos
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

